Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Peptide
RARRES3
Reactivity: Human
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN982668
$160.46
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 11 to 17 Business Days
Quick Overview for Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Peptide (ABIN982668)
Target
RARRES3
(Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-RARRES3 antibody (Catalog #: ARP46474_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RARRES3 (Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
-
Background
-
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES3 is thought act as a tumor suppressor or growth regulator.Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.
Alias Symbols: HRASLS4, MGC8906, RIG1, TIG3, PLA1/2-3
Protein Interaction Partner: TGM1,HRAS,TGM1,RNF135,TRIM25
Protein Size: 164 -
Molecular Weight
- 18 kDa
-
Gene ID
- 5920
-
NCBI Accession
- NM_004585, NP_004576
-
UniProt
- Q9UL19
Target
-
You are here:
